BACKGROUND: Abnormalities of basal ganglia structure in schizophrenia have been attributed to the effects of antipsychotic drugs. Our aim was to test the hypothesis that abnormalities of basal ganglia structure are intrinsic features of schizophrenia by assessing basal ganglia volume and shape in the unaffected siblings of schizophrenia subjects. METHOD: The study involved 25 pairs of schizophrenia subjects and their unaffected siblings and 40 pairs of healthy control subjects and their siblings. Large-deformation, high-dimensional brain mapping was used to obtain surface representations of the caudate, putamen, and globus pallidus. Surfaces were derived from transformations of anatomic templates, and shapes were analyzed using reduced-dimensional measures of surface variability (i.e., principal components and canonical analysis). Canonical functions were derived using schizophrenia and control groups and were then used to compare shapes in the sibling groups. To visualize shape differences, maps of the estimated surface displacement between groups were created. RESULTS: In the caudate, putamen, and globus pallidus, the degree of shape abnormality observed in the siblings of the schizophrenia subjects was intermediate between the schizophrenia and control subjects. In the schizophrenia subjects, significant correlations were observed between measures of caudate, putamen, and globus pallidus structure and the selected measures of lifetime psychopathology. CONCLUSIONS: Attenuated abnormalities of basal ganglia structure are present in the unaffected siblings of schizophrenia subjects. This finding implies that basal ganglia structural abnormalities observed in subjects with schizophrenia are at least in part an intrinsic feature of the illness.
BACKGROUND:Abnormalities of basal ganglia structure in schizophrenia have been attributed to the effects of antipsychotic drugs. Our aim was to test the hypothesis that abnormalities of basal ganglia structure are intrinsic features of schizophrenia by assessing basal ganglia volume and shape in the unaffected siblings of schizophrenia subjects. METHOD: The study involved 25 pairs of schizophrenia subjects and their unaffected siblings and 40 pairs of healthy control subjects and their siblings. Large-deformation, high-dimensional brain mapping was used to obtain surface representations of the caudate, putamen, and globus pallidus. Surfaces were derived from transformations of anatomic templates, and shapes were analyzed using reduced-dimensional measures of surface variability (i.e., principal components and canonical analysis). Canonical functions were derived using schizophrenia and control groups and were then used to compare shapes in the sibling groups. To visualize shape differences, maps of the estimated surface displacement between groups were created. RESULTS: In the caudate, putamen, and globus pallidus, the degree of shape abnormality observed in the siblings of the schizophrenia subjects was intermediate between the schizophrenia and control subjects. In the schizophrenia subjects, significant correlations were observed between measures of caudate, putamen, and globus pallidus structure and the selected measures of lifetime psychopathology. CONCLUSIONS:Attenuated abnormalities of basal ganglia structure are present in the unaffected siblings of schizophrenia subjects. This finding implies that basal ganglia structural abnormalities observed in subjects with schizophrenia are at least in part an intrinsic feature of the illness.
Authors: M Miller; A Banerjee; G Christensen; S Joshi; N Khaneja; U Grenander; L Matejic Journal: Stat Methods Med Res Date: 1997-09 Impact factor: 3.021
Authors: M H Chakos; J A Lieberman; R M Bilder; M Borenstein; G Lerner; B Bogerts; H Wu; B Kinon; M Ashtari Journal: Am J Psychiatry Date: 1994-10 Impact factor: 18.112
Authors: Zainab Delawalla; Deanna M Barch; Jennifer L Fisher Eastep; Emily S Thomason; Melissa J Hanewinkel; Paul A Thompson; John G Csernansky Journal: Schizophr Bull Date: 2006-05-19 Impact factor: 9.306
Authors: Donna J Lang; Lili C Kopala; Robert A Vandorpe; Qing Rui; Geoffrey N Smith; Vina M Goghari; Jocelyne S Lapointe; William G Honer Journal: Am J Psychiatry Date: 2004-10 Impact factor: 18.112
Authors: Howard C Margolese; Leslie Malchy; Juan Carlos Negrete; Raymond Tempier; Kathryn Gill Journal: Schizophr Res Date: 2004-04-01 Impact factor: 4.939
Authors: Ulrich Ettinger; Anne Schmechtig; Timothea Toulopoulou; Charmaine Borg; Claire Orrells; Sheena Owens; Kazunori Matsumoto; Neeltje E van Haren; Mei-Hua Hall; Veena Kumari; Philip K McGuire; Robin M Murray; Marco Picchioni Journal: Schizophr Bull Date: 2010-06-10 Impact factor: 9.306
Authors: Toshikazu Ikuta; Delbert G Robinson; Juan A Gallego; Bart D Peters; Patricia Gruner; John Kane; Majnu John; Serge Sevy; Anil K Malhotra; Philip R Szeszko Journal: Psychiatry Res Date: 2013-10-10 Impact factor: 3.222
Authors: Fay Y Womer; Lei Wang; Kathryn I Alpert; Matthew J Smith; John G Csernansky; Deanna M Barch; Daniel Mamah Journal: Psychiatry Res Date: 2014-06-06 Impact factor: 3.222
Authors: M Mallar Chakravarty; Judith L Rapoport; Jay N Giedd; Armin Raznahan; Philip Shaw; D Louis Collins; Jason P Lerch; Nitin Gogtay Journal: Hum Brain Mapp Date: 2014-12-11 Impact factor: 5.038
Authors: Yaling Yang; Keith H Nuechterlein; Owen R Phillips; Boris Gutman; Florian Kurth; Ivo Dinov; Paul M Thompson; Robert F Asarnow; Arthur W Toga; Katherine L Narr Journal: Hum Brain Mapp Date: 2012-09 Impact factor: 5.038
Authors: Daniel R Calabrese; Lei Wang; Michael P Harms; J Tilak Ratnanather; Deanna M Barch; C Robert Cloninger; Paul A Thompson; Michael I Miller; John G Csernansky Journal: Schizophr Res Date: 2008-08-09 Impact factor: 4.939
Authors: Muqing Lin; Peter T Fwu; Claudia Buss; Elysia P Davis; Kevin Head; L Tugan Muftuler; Curt A Sandman; Min-Ying Su Journal: Int J Dev Neurosci Date: 2013-06-14 Impact factor: 2.457